SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-298075
Filing Date
2022-12-05
Accepted
2022-12-05 09:27:08
Documents
18
Period of Report
2022-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d335056d8k.htm   iXBRL 8-K 52521
2 EX-10.1 d335056dex101.htm EX-10.1 13599
3 EX-10.2 d335056dex102.htm EX-10.2 36220
4 EX-10.3 d335056dex103.htm EX-10.3 69848
5 EX-10.4 d335056dex104.htm EX-10.4 22387
6 EX-99.1 d335056dex991.htm EX-99.1 19496
10 GRAPHIC g335056g1205072236120.jpg GRAPHIC 3121
  Complete submission text file 0001193125-22-298075.txt   390528

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ymtx-20221205.xsd EX-101.SCH 2841
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymtx-20221205_lab.xml EX-101.LAB 17994
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymtx-20221205_pre.xml EX-101.PRE 11255
12 EXTRACTED XBRL INSTANCE DOCUMENT d335056d8k_htm.xml XML 3397
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 221443909
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences